Healthcare + AI: Google Leads Push for AI-Designed Drugs, How AI Is Transforming ePrescribing, Eleos Health Raises $60M for Behavioral Health Expansion

At Healthcare + AI, we explore the latest trends and insights in healthcare and AI. Everything you need. Nothing you don’t.

Today’s features:

• Google’s Isomorphic Labs, Insilico Push AI-Designed Drugs Toward Trial

• Yidu Tech Takes AI Healthcare Global with Major Expansion

• Eleos Health Raises $60M Series C for Behavioral Health Tech Expansion

Google’s Isomorphic Labs, Insilico Push AI-Designed Drugs Toward Trials

Driving the news: Google’s DeepMind spinoff, Isomorphic Labs, is accelerating AI-designed drug development, with clinical trials expected by year-end. CEO Demis Hassabis, speaking at Davos, highlighted AI’s ability to model molecular interactions and optimize treatments. Insilico Medicine and Exscientia are also advancing AI-driven therapeutics, signaling a transformation in drug discovery.

Why it matters: AI could slash drug development timelines, speeding up treatments for cancer, neurodegeneration, and other diseases.

What’s next: AI-designed drugs are moving from labs to human trials, with pharma giants watching closely. Read more

AI Is Transforming ePrescribing—Here’s How

Artificial intelligence is reshaping ePrescribing, the digital process of generating and transmitting prescriptions, with major implications for patients, providers, and pharmacies. AI-driven solutions are enhancing medication adherence, reducing administrative burdens, and improving prescription safety. “We need more innovation on ePrescribing technology,” experts argue, highlighting AI’s role in optimizing workflows and ensuring patients get their medications faster.

Driving the news:

• AI-powered tools will give patients instant access to price comparisons, helping them choose the most affordable medication option.

• Providers will spend less time on prior authorizations as AI automates approvals and flags potential coverage issues.

• Pharmacies will see fewer errors, as AI enhances medication reconciliation and catches prescription mismatches before they reach patients.

With AI integration, ePrescribing could finally eliminate many of the delays and frustrations that have plagued the system. Read more.

Yidu Tech Takes AI Healthcare Global with Major Expansion

At Davos 2025, China’s Yidu Tech announced an aggressive global expansion of its AI-driven healthcare solutions.

The company, known for its expertise in big data and artificial intelligence, is scaling its technology to improve clinical decision-making, drug discovery, and population health management worldwide.

Why it matters: By harnessing AI, Yidu Tech aims to bridge healthcare gaps in underserved regions while optimizing efficiency in developed markets. This expansion underscores the growing demand for AI-powered solutions in tackling global health challenges.

Eleos Health Raises $60M Series C for Behavioral Health Tech Expansion

Driving the news: Eleos Health secured $60 million in Series C funding to expand its AI-powered solutions for behavioral health. The company’s platform aims to improve mental health treatment by automating documentation and streamlining clinical workflows, enhancing therapist productivity.

Why it matters: This funding will accelerate Eleos Health’s mission to improve mental health care delivery, especially in underserved areas. Read more